Edition:
United Kingdom

Vericel Corp (VCEL.OQ)

VCEL.OQ on NASDAQ Stock Exchange Capital Market

7.25USD
16 Feb 2018
Change (% chg)

$-0.25 (-3.33%)
Prev Close
$7.50
Open
$7.55
Day's High
$7.60
Day's Low
$7.00
Volume
74,900
Avg. Vol
97,427
52-wk High
$8.20
52-wk Low
$2.35

Latest Key Developments (Source: Significant Developments)

Vericel Initiates Collaboration with Innovative Cellular Therapeutics
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Vericel Corp ::VERICEL CORP - ‍INITIATION OF LICENSE AGREEMENT WITH INNOVATIVE CELLULAR THERAPEUTICS FOLLOWING RECEIPT OF $5.1 MILLION UPFRONT,WARRANT PAYMENT FROM ICT​.VERICEL - ‍UNDER DEAL,ICT WILL DEVELOP,DISTRIBUTE MACI EPICE,IXMYELOCEL-T,CARTICEL IN GREATER CHINA,SOUTH KOREA, SINGAPORE, OTHER COUNTRIES IN REGION​.  Full Article

Vericel Enters Into Expanded $25 Million Debt Facilities With Silicon Valley Bank And Midcap Financial
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Vericel Corp ::VERICEL ENTERS INTO EXPANDED $25 MILLION DEBT FACILITIES WITH SILICON VALLEY BANK AND MIDCAP FINANCIAL TO SUPPORT ACCELERATING MACI UPTAKE AND INCREASED EPICEL USAGE.VERICEL-ENTERED INTO EXPANDED $15 MILLION TERM LOAN, RETAINED EXISTING $10 MILLION REVOLVING LINE OF CREDIT WITH SILICON VALLEY BANK,MIDCAP FINANCIAL SERVICES​.  Full Article

Vericel reports Q3 loss per share $0.16
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Vericel Corp :Vericel reports third-quarter 2017 financial results.Q3 loss per share $0.16.Q3 revenue $14.3 million versus I/B/E/S view $13.9 million.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.Vericel Corp - ‍As of September 30, 2017, company had $15.5 million in cash compared to $23.0 million in cash at December 31, 2016​.  Full Article

Vericel enters into sales agreement to sell co's common stock having aggregate sale price up to $25 million
Tuesday, 11 Oct 2016 

Vericel Corp :Vericel - entered sales agreement to sell co's common stock having aggregate sale price up to $25 million , through an at the market offering program.  Full Article

Vericel reports Q2 adjusted loss per share $0.21
Monday, 8 Aug 2016 

Vericel Corp : Reports second-quarter 2016 financial results . Q2 revenue $12.8 million . Q2 adjusted loss per share $0.21 .Q2 GAAP loss per share $0.22.  Full Article

Vericel Q1 loss per share $0.24
Tuesday, 10 May 2016 

Vericel : Quarter 2016 financial results . Q1 adjusted loss per share $0.08 . Q1 gaap loss per share $0.24 .Q1 revenue $14.1 million.  Full Article

BRIEF-Vericel Initiates Collaboration with Innovative Cellular Therapeutics   

* VERICEL CORP - ‍INITIATION OF LICENSE AGREEMENT WITH INNOVATIVE CELLULAR THERAPEUTICS FOLLOWING RECEIPT OF $5.1 MILLION UPFRONT,WARRANT PAYMENT FROM ICT​